Cargando…
COVID-19: inflammatory responses, structure-based drug design and potential therapeutics
The COVID-19 pandemic caused by SARS-CoV-2 is responsible for the global health emergency. Here, we explore the diverse mechanisms of SARS-CoV-induced inflammation. We presume that SARS-CoV-2 likely contributes analogous inflammatory responses. Possible therapeutic mechanisms for reducing SARS-CoV-2...
Autores principales: | Tripathi, Neetu, Tripathi, Neeraj, Goshisht, Manoj Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782055/ https://www.ncbi.nlm.nih.gov/pubmed/33400086 http://dx.doi.org/10.1007/s11030-020-10176-1 |
Ejemplares similares
-
Organelle-targeting ratiometric fluorescent probes: design principles, detection mechanisms, bio-applications, and challenges
por: Goshisht, Manoj Kumar, et al.
Publicado: (2023) -
New cellular and molecular approaches to ageing brain
por: Tripathi, Anurag
Publicado: (2012) -
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to
por: Ojha, Probir Kumar, et al.
Publicado: (2020) -
Therapeutic potential of pyrrole and pyrrolidine analogs: an update
por: Jeelan Basha, N., et al.
Publicado: (2022) -
Recent advances in targeted protein degraders as potential therapeutic agents
por: Yang, Na, et al.
Publicado: (2023)